Early-Stage Cardiovascular, Spine/Orthopedic, Oncology, Drug Delivery, Biomaterials and Imaging Companies from around the World Are among the 50 Companies That Will Present at Medtech Insight's In3 Europe Investment and Partnering Conference.
Sept. 20-21, 2005 The Crowne Plaza Brussels City Centre Hotel Brussels, Belgium
Medtech Insight, a division of Windhover Information, has announced that nearly 30 promising young medical technology companies are confirmed to present thus far at its "Investment In Innovation (In3) EUROPE: A Preview of Early-Stage Medical Technology Companies" conference in Brussels, Belgium, Sept. 20-21, out of the 50 that will present in total.
In3 EUROPE, Medtech Insight's first "Investment In Innovation" medical technology strategic partnering and investment event outside of the U.S., will be held at The Crowne Plaza Brussels City Centre Hotel, and will bring together emerging medical technology companies from around the world seeking funding, acquisition and/or strategic partnership with major medical technology and investment dealmakers. Presenting companies confirmed thus far with new technologies that address a variety of high-growth clinical areas include: ABMI, Aeres Medical, Al Semi, Ars Arthro, Biomarker Technologies, Biomedix, Biophan-Europe, Bioretec, Cardio3, Clearant, eRAD-Image Medical, Hemoteq, HIRUDICA, Innovent Medical Solutions, Medical Tactile, MILLiMED, MINVASYS, Novovascular, PlaCor, Power Paper, QuiCare, Scientific Intake, Skeletal Kinetics, Spinelix, Suriasis, Valor Medical, Vascular Reconditioning, and ViOPtix (50 presenters at time of event). Regularly updated event details are posted on the Medtech Insight Web site at http://www.medtechinsight.com/in3-europe-01.html.
The In3 EUROPE program will also feature presentations by Olav Bergheim, formerly a general partner at Domain Associates who recently launched a new healthcare investment firm called Fjord Ventures, and Stefan Widensohler, president and CEO of KRAUTH Medical, a leading European medical supply distributor primarily serving the German healthcare market.
The event will also feature an informative and interactive industry panel discussion titled "Venture Investing from a European Perspective." The distinguished panel, who will discuss current factors impacting venture investing in the European healthcare marketplace, will feature Antoine Papiernik, managing partner at Sofinnova Partners; Berthold Hackl, managing partner at Heidelberg Innovation; and Daniel Gottlieb, group manager, business development, international at Guidant Compass, with others to be announced. The panel will be moderated by David Cassak, managing partner at Windhover Information. Event co-sponsors include Battelle, Business Wire, Factory, Ronald Trahan Associates, and TforG.
The company's past U.S. "Investment In Innovation" conferences have hosted over 560 early-stage presenting medical companies and more than 4,800 attendees, making it one of the most successful networking and partnering events in the medical device industry. For more information or to register to attend the In3 EUROPE event, contact Kristy Grimes of Medtech Insight at 480-985-9512, e-mail firstname.lastname@example.org, or visit the Medtech Insight Web site at http://www.medtechinsight.com/in3-europe-01.html. Through July 29, attendees registering for the conference can save $300 off the $1,495 registration fee.
A division of Windhover Information Inc., Medtech Insight is the leading provider of business information and market intelligence for the medical technology marketplace. For more on the company's products and services, please see www.medtechinsight.com.
|Printer friendly Cite/link Email Feedback|
|Date:||Jul 11, 2005|
|Previous Article:||Imagistics International Inc. Second Quarter 2005 Earnings Announcement Conference Call and Audio Webcast Invitation - August 4, 2005.|
|Next Article:||Duos Technologies, Inc. Awarded Contract to Harden Sensitive Rail Corridor Through Washington D.C.|